BAMLANIVIMAB vs BARICITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
BAMLANIVIMAB vs BARICITINIB: Safety Overview
| Metric | BAMLANIVIMAB | BARICITINIB |
|---|---|---|
| Total FAERS Reports | 5,280 | 8,108 |
| Deaths Reported | 307 | 717 |
| Death Rate | 5.8% | 8.8% |
| Hospitalizations | 2,175 | 2,498 |
| Average Patient Age | 63.6 yrs | 58.2 yrs |
| % Female Patients | 50.5% | 67.9% |
| FDA Approval Date | N/A | Aug 8, 2025 |
| Manufacturer | N/A | Eli Lilly and Company |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |